Endocrine and metabolic late effects in childhood cancer survivors in Germany: the VersKiK study

Our study highlights the increased vulnerability of CCS to endocrine and metabolic diseases compared to the general population and underscores the need for risk-adapted surveillance during the whole survivorship trajectory.